These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1125 related articles for article (PubMed ID: 9660836)

  • 1. Identification of a novel inhibitor of mitogen-activated protein kinase kinase.
    Favata MF; Horiuchi KY; Manos EJ; Daulerio AJ; Stradley DA; Feeser WS; Van Dyk DE; Pitts WJ; Earl RA; Hobbs F; Copeland RA; Magolda RL; Scherle PA; Trzaskos JM
    J Biol Chem; 1998 Jul; 273(29):18623-32. PubMed ID: 9660836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of raf-1 by kinase suppressor of ras is inhibited by "MEK-specific" inhibitors PD 098059 and U0126 in differentiating HL60 cells.
    Wang X; Studzinski GP
    Exp Cell Res; 2001 Aug; 268(2):294-300. PubMed ID: 11478855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo.
    Alessi DR; Cuenda A; Cohen P; Dudley DT; Saltiel AR
    J Biol Chem; 1995 Nov; 270(46):27489-94. PubMed ID: 7499206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Raf/MEK/ERK pathway controls protein kinase C-mediated p70S6K activation in adult cardiac muscle cells.
    Iijima Y; Laser M; Shiraishi H; Willey CD; Sundaravadivel B; Xu L; McDermott PJ; Kuppuswamy D
    J Biol Chem; 2002 Jun; 277(25):23065-75. PubMed ID: 11940578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
    Wen-Sheng W
    Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets.
    McNicol A; Jackson EC
    Biochem Pharmacol; 2003 Apr; 65(8):1243-50. PubMed ID: 12694865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.
    Schuringa JJ; Jonk LJ; Dokter WH; Vellenga E; Kruijer W
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):89-96. PubMed ID: 10727406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression.
    Kim SJ; Kahn CR
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):621-7. PubMed ID: 9169593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes.
    Andrieux L; Langouët S; Fautrel A; Ezan F; Krauser JA; Savouret JF; Guengerich FP; Baffet G; Guillouzo A
    Mol Pharmacol; 2004 Apr; 65(4):934-43. PubMed ID: 15044623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
    Gum R; Wang H; Lengyel E; Juarez J; Boyd D
    Oncogene; 1997 Mar; 14(12):1481-93. PubMed ID: 9136992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells.
    Watters JJ; Chun TY; Kim YN; Bertics PJ; Gorski J
    Mol Endocrinol; 2000 Nov; 14(11):1872-81. PubMed ID: 11075818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2.
    Lents NH; Keenan SM; Bellone C; Baldassare JJ
    J Biol Chem; 2002 Dec; 277(49):47469-75. PubMed ID: 12359725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion.
    Hartkamp J; Troppmair J; Rapp UR
    Cancer Res; 1999 May; 59(9):2195-202. PubMed ID: 10232608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Akt1 by human 5-hydroxytryptamine (serotonin)1B receptors is sensitive to inhibitors of MEK.
    Hsu EH; Lochan AC; Cowen DS
    J Pharmacol Exp Ther; 2001 Aug; 298(2):825-32. PubMed ID: 11454948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.
    Fukazawa H; Noguchi K; Murakami Y; Uehara Y
    Mol Cancer Ther; 2002 Mar; 1(5):303-9. PubMed ID: 12489846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
    Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
    Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products.
    Duncia JV; Santella JB; Higley CA; Pitts WJ; Wityak J; Frietze WE; Rankin FW; Sun JH; Earl RA; Tabaka AC; Teleha CA; Blom KF; Favata MF; Manos EJ; Daulerio AJ; Stradley DA; Horiuchi K; Copeland RA; Scherle PA; Trzaskos JM; Magolda RL; Trainor GL; Wexler RR; Hobbs FW; Olson RE
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2839-44. PubMed ID: 9873633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.